Further in C1858T PTPN22 SLE carriers enhanced expression of PD-1 was associated with reduced Tregs suppressive capacity and increased autoreactive Teff proliferation contributing to disease flares of clinically active disease (33). Here, PTPN22 is linked to systemic lupus erythematosus.